TY - JOUR
T1 - Personalized medicine
T2 - Where do we go from here?
AU - Pan, Dipanjan
N1 - Publisher Copyright:
© Springer International Publishing Switzerland 2015.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - The past decade has seen a surplus of nanotechnology-based methodologies for “theranostic” application, sensors, and real-time monitoring of biological events, therapy, and image-guided precision drug delivery. While nanotechnology offers great promise to address some of the critical clinical challenges, the future of this technology toward personalized medicine will largely be predisposed by design principles for developing translatable, “safer” nanoplatforms in concert with imaging agents, therapy, and homing ligands.
AB - The past decade has seen a surplus of nanotechnology-based methodologies for “theranostic” application, sensors, and real-time monitoring of biological events, therapy, and image-guided precision drug delivery. While nanotechnology offers great promise to address some of the critical clinical challenges, the future of this technology toward personalized medicine will largely be predisposed by design principles for developing translatable, “safer” nanoplatforms in concert with imaging agents, therapy, and homing ligands.
UR - http://www.scopus.com/inward/record.url?scp=84975842441&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84975842441&partnerID=8YFLogxK
U2 - 10.1007/7355_2015_95
DO - 10.1007/7355_2015_95
M3 - Article
AN - SCOPUS:84975842441
SN - 1862-2461
VL - 20
SP - 121
EP - 130
JO - Topics in Medicinal Chemistry
JF - Topics in Medicinal Chemistry
ER -